Literature DB >> 30403984

Revisiting the Warburg Effect: Some Tumors Hold Their Breath.

Sydney M Sanderson1, Jason W Locasale2.   

Abstract

Studies have shown that tumors commonly exhibit normal or enhanced respiration in addition to glycolytic metabolism. In this issue, Courtney et al. (2018) report a reduction in mitochondrial function in kidney cancer patients and thus a classic "Warburg Effect" that further illustrates the heterogeneity of human cancer metabolism.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30403984      PMCID： PMC6719776          DOI： 10.1016/j.cmet.2018.10.011

Source DB:  PubMed          Journal:  Cell Metab        ISSN： 1550-4131            Impact factor:   27.287


  13 in total

1.  Autophagy inhibitors increase the susceptibility of KRAS-mutant human colorectal cancer cells to a combined treatment of 2-deoxy-D-glucose and lovastatin.

Authors:  Xiao-Ming Huang; Jia-Jun Huang; Jing-Jing Du; Na Zhang; Ze Long; You Yang; Fang-Fang Zhong; Bo-Wen Zheng; Yun-Fu Shen; Zhe Huang; Xiang Qin; Jun-He Chen; Qian-Yu Lin; Wan-Jun Lin; Wen-Zhe Ma
Journal:  Acta Pharmacol Sin       Date:  2021-02-19       Impact factor: 6.150

2.  Cancer cells with defective oxidative phosphorylation require endoplasmic reticulum-to-mitochondria Ca2+ transfer for survival.

Authors:  Cesar Cardenas; Alenka Lovy; Eduardo Silva-Pavez; Felix Urra; Craig Mizzoni; Ulises Ahumada-Castro; Galdo Bustos; Fabian Jaňa; Pablo Cruz; Paula Farias; Elizabeth Mendoza; Hernan Huerta; Paola Murgas; Martin Hunter; Melany Rios; Oscar Cerda; Irene Georgakoudi; Armen Zakarian; Jordi Molgó; J Kevin Foskett
Journal:  Sci Signal       Date:  2020-07-14       Impact factor: 9.517

3.  Targeting the transcription factor receptor LXR to treat clear cell renal cell carcinoma: agonist or inverse agonist?

Authors:  Guangzhen Wu; Qinglian Wang; Yingkun Xu; Jianyi Li; Hongge Zhang; Guanghui Qi; Qinghua Xia
Journal:  Cell Death Dis       Date:  2019-05-28       Impact factor: 8.469

4.  Metabolic determination of cell fate through selective inheritance of mitochondria.

Authors:  Julia Döhla; Emilia Kuuluvainen; Nadja Gebert; Ana Amaral; Johanna I Englund; Swetha Gopalakrishnan; Svetlana Konovalova; Anni I Nieminen; Ella S Salminen; Rubén Torregrosa Muñumer; Kati Ahlqvist; Yang Yang; Hien Bui; Timo Otonkoski; Reijo Käkelä; Ville Hietakangas; Henna Tyynismaa; Alessandro Ori; Pekka Katajisto
Journal:  Nat Cell Biol       Date:  2022-02-14       Impact factor: 28.213

Review 5.  Mapping the Metabolic Networks of Tumor Cells and Cancer-Associated Fibroblasts.

Authors:  Jessica Karta; Ysaline Bossicard; Konstantinos Kotzamanis; Helmut Dolznig; Elisabeth Letellier
Journal:  Cells       Date:  2021-02-02       Impact factor: 6.600

6.  Diethyldithiocarbamate-copper complex (CuET) inhibits colorectal cancer progression via miR-16-5p and 15b-5p/ALDH1A3/PKM2 axis-mediated aerobic glycolysis pathway.

Authors:  Xin Huang; Yichao Hou; Xiaoling Weng; Wenjing Pang; Lidan Hou; Yu Liang; Yu Wang; Leilei Du; Tianqi Wu; Mengfei Yao; Jianhua Wang; Xiangjun Meng
Journal:  Oncogenesis       Date:  2021-01-08       Impact factor: 7.485

7.  Iron Regulates the Warburg Effect and Ferroptosis in Colorectal Cancer.

Authors:  Yin Yuan; Shuo Ni; Aoxiang Zhuge; Bo Li; Lanjuan Li
Journal:  Front Oncol       Date:  2021-05-18       Impact factor: 6.244

8.  MTFR2 Promotes the Proliferation, Migration, and Invasion of Oral Squamous Carcinoma by Switching OXPHOS to Glycolysis.

Authors:  Wei Wang; Meihua Xiong; Lin Jiang; Zean Chen; Yisen Shao
Journal:  Front Oncol       Date:  2020-05-27       Impact factor: 6.244

9.  A yeast phenomic model for the influence of Warburg metabolism on genetic buffering of doxorubicin.

Authors:  Sean M Santos; John L Hartman
Journal:  Cancer Metab       Date:  2019-10-23

10.  CircECE1 activates energy metabolism in osteosarcoma by stabilizing c-Myc.

Authors:  Shuying Shen; Teng Yao; Yining Xu; Deguang Zhang; Shunwu Fan; Jianjun Ma
Journal:  Mol Cancer       Date:  2020-10-26       Impact factor: 27.401
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.